See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated

Endocrinology Article Archives

August 2011

Metformin Helped My Type 1 Diabetes

My name is Katherine Marple, and I've had type 1 diabetes for 13 years. I'm the first in my family to have the disease, so I've done most of the research and made most of the discoveries on my own. One of those discoveries was the power of metformin (in addition to insulin) to help me control my diabetes.

comments 16 comments - Posted Aug 18, 2011

July 2011

New Website Facilitates Communication Between Type 2 Patients and Their Physicians

People with type 2 diabetes often find visits with their physicians frustrating.  Dr. Jeffrey Mechanick, MD, FACE, FACP, Secretary of the American Association of Clinical Endocrinologists (AACE), observes, "Many times when patients come to the doctor, the first thing that they say is really what's on their mind--that's their top priority. But oftentimes physicians don't address that at all. Instead, they move on to what's on their own agenda."

comments 3 comments - Posted Jul 31, 2011

April 2011

Be Thankful: A Letter of Gratitude

If you, like me, have diabetes, you realize upon reflection that you are, despite the constant demands of the disease, blessed.  Somewhere, sometime, you have benefited from the kindness, professionalism, and genuine concern of a medical professional, be it a nurse, pharmacist, dietitian, physician, therapist, or supporting staff.   

comments 7 comments - Posted Apr 7, 2011

February 2011

Does Coffee Protect Against Type 2 Diabetes?

Folks who need that morning cup of coffee to get going may be protecting themselves from type 2 diabetes, a new study suggests. UCLA researchers wrote in the journal Diabetes last month that drinking four cups of coffee a day reduced women's chance of developing type 2 by a bit less than half. What's more, the scientists point to a specific reason why all that java has a beneficial effect: a protein known as sex hormone-binding globulin (SHBG). Scientists have suspected for some time that SHBG was connected to diabetes development.

comments 0 comments - Posted Feb 19, 2011

Mouse Study Eliminates Need for Insulin by Eliminating Glucagon

Can't make insulin? That might not be a problem, according to Dr. Roger Unger, the lead researcher on a mouse study out of UT Southwestern Medical Center. As Dr. Unger stated in a press release, his findings "suggest that if there is no glucagon, it doesn't matter if you don't have insulin....In adulthood, at least with respect to glucose metabolism, the role of insulin is to control glucagon. And if you don't have glucagon, then you don't need insulin...If diabetes is defined as restoration of glucose homeostasis to normal, then this treatment can perhaps be considered very close to a ‘cure.' "

comments 1 comment - Posted Feb 16, 2011

Last Patient Completes the EU Phase III Study of Diamyd® Antigen Based Therapy for Type 1 Diabetes

The final patient has performed the last visit of the main study period in Diamyd Medical's European Phase III study. Treatment with the antigen based therapy Diamyd® is made to investigate whether beta cell function and thereby blood sugar control can be preserved in children and adolescents with new onset type 1 diabetes. The top line results from this study are expected to be reported as planned, in late spring 2011.

comments 0 comments - Posted Feb 15, 2011

Type 1 Diabetes Associated With Common Cold Virus

It's generally thought that a genetic predisposition to type 1 diabetes is not enough to develop the disease, but that an environmental trigger is required to activate it. Researchers are not sure what that environmental trigger is, but enteroviruses have been under suspicion for quite a while. Enteroviruses are the second leading cause of viral colds in children.

comments 1 comment - Posted Feb 8, 2011

January 2011

"The Hormone of Darkness" Won't Come Out in the Light

Keeping the lights on all night might keep away the monsters under the bed, but it also keeps away the "hormone of darkness," melatonin, according to a new study in the Journal of Clinical Endocrinology and Metabolism. Melatonin, which is secreted into the blood by the brain's pineal gland at night, is involved in the circadian rhythm. Scientists believe that disrupting circadian rhythms can contribute to metabolic disease. Specifically, melatonin receptor genes have been linked to type 2 diabetes. Melatonin is also a powerful antioxidant that may help prevent cancer.

comments 3 comments - Posted Jan 19, 2011

December 2010

Stem cells used to make pancreas, gut cells

(Reuters) - Stem cells can be transformed into the pancreatic cells needed to treat diabetes and into complex layers of intestinal tissue, scientists demonstrated in two experiments reported on Sunday.

comments 6 comments - Posted Dec 13, 2010

October 2010

Surgeons Create Functional Artificial Pancreatic Tissue

In a proof-of-concept study presented at the 2010 Annual Clinical Congress of the American College of Surgeons, the researchers note that the matrix not only helps to understand the micro-architecture of the pancreas, but also prolongs the survival and preserves the function of the islets. Islets survived longer in the bio-artificial matrix than in conventional transplantation sites, and they produced significantly more insulin when challenged with glucose.

comments 0 comments - Posted Oct 30, 2010

Continuous Glucose Monitoring Consensus Statement Released by AACE

JACKSONVILLE, FL - October 13, 2010 - The American Association of Clinical Endocrinologists (AACE) today published a consensus statement for continuous glucose monitoring (CGM) online, and will be published in the next issue of the association's official medical journal Endocrine Practice.

comments 0 comments - Posted Oct 14, 2010

September 2010

New Blood Markers for Type 2 Diabetes May Help to Identify Patients at Risk

For the first time, scientists have found that blood levels of some ribonucleic acids (microRNAs) are different among people with type 2 diabetes and those who subsequently develop the disease compared to healthy controls, according to research reported in Circulation Research: Journal of the American Heart Association.

comments 0 comments - Posted Sep 22, 2010

Kids and Diabetes Risk: Do Chromosomes Hold New Clues?

Children who have a high risk of developing type 2 diabetes might be identified earlier by way of tell-tale genetic indicators known as biomarkers. Some of those new biomarkers might be pinpointed in research led by Nancy F. Butte and funded by the U.S. Department of Agriculture (USDA) and the U.S. Department of Health and Human Service's National Institutes of Health.

comments 0 comments - Posted Sep 22, 2010

Rogue Protein May Trigger Diabetes

The presence of amyloid protein may produce a chain reaction which destroys vital insulin-producing cells. Researchers based in Dublin, writing in the journal Nature Immunology, say future drugs could target this process. Amyloid is implicated in many other diseases - most notably Alzheimer's.

comments 0 comments - Posted Sep 17, 2010

Diabetes and Autoimmunity

The JDRF is celebrating its 40th anniversary this year. A lot has changed in the past four decades. One change has to do with the organization's name. JDRF stands for Juvenile Diabetes Research Foundation. Years ago we called what we now know as type 1 diabetes, Juvenile Onset Diabetes Mellitus (JODM). We called it that because we knew (or thought we knew) it was the kind of diabetes that occurred in children. We now know that type 1 diabetes occurs in people of all age groups. There was a lot we didn't know 40 years ago, one of which was that type 1 diabetes is an autoimmune disease.

comments 0 comments - Posted Sep 16, 2010

Joslin 50-Year Medalists Give Clues to Cures

In type 1 diabetes, the body relentlessly attacks and destroys its own insulin-producing pancreatic beta cells. But a study by Joslin Diabetes Center scientists now has firmly established that some of these cells endure for many decades in a small group of people with the disease-offering clues to potential treatments for preserving and even restoring the crucial cell population.

comments 0 comments - Posted Sep 14, 2010

Immune System Genes Show Links to Type 1 Diabetes

The exact cause of type 1 diabetes is still unknown, but international researchers have found a link between the blood sugar disorder and a network of immune system genes.

comments 0 comments - Posted Sep 13, 2010

Vietnam Vets, Agent Orange, and Type 2 Diabetes

Despite the lack of a strong link between type 2 diabetes and Agent Orange, the government is paying Vietnam veterans hundreds of millions of dollars for the disease on the basis of Agent Orange exposure.

comments 1 comment - Posted Sep 12, 2010

Type 2 Diabetes Raises Alzheimer's Disease Risk

Type 2 diabetes and Alzheimer's disease are two distressing, but increasingly common, diseases seen in our aging population. At some point in the future, they may well overwhelm the healthcare system.

comments 0 comments - Posted Sep 5, 2010

July 2010

More from ACCORD

In people with longstanding type 2 diabetes who are at high risk for heart attack and stroke, lowering blood sugar to near-normal levels did not delay the combined risk of diabetic damage to kidneys, eyes, or nerves, but did delay several other signs of diabetic damage, a study has found. The intensive glucose treatment was compared with standard glucose control.

comments 0 comments - Posted Jul 2, 2010

Coconut Oil Could Reduce The Symptoms Of Type 2 Diabetes

A diet including coconut oil, a medium chain fatty acid (MCFA), helps combat insulin resistance. Insulin resistance is the inability of cells to respond to insulin and take in glucose for energy. The pancreas tries to compensate for insulin resistance by producing even more insulin, but eventually glucose accumulates in the bloodstream. Over time, insulin resistance and obesity can lead to pre-diabetes or full-blown type 2 diabetes. 

comments 0 comments - Posted Jul 1, 2010

June 2010

Double Transplantation Treatment for Type 1 Diabetes

City of Hope researchers have found that bone marrow transplantation with islet cell transplantation shows promise as a treatment for late-stage type 1 diabetes. This combination may enable patients to make their own insulin again.  Results from laboratory research led by Defu Zeng, MD, associate professor in the departments of Diabetes Research and Hematology & Hematopoietic Cell Transplantation at City of Hope, were published online this month in the journal Diabetes.

comments 0 comments - Posted Jun 25, 2010

Scientists Have Found the Peptide Trigger for Type 1 Diabetes in Animal Tests

Researchers from the National Jewish Health and University of Colorado Anschutz Medical Campus have found a specific protein fragment, or peptide, that stimulates an immune system attack resulting in diabetes. Their experiments in mice contradict conventional wisdom about such peptides and support work by scientists studying autoimmune diseases.

comments 0 comments - Posted Jun 24, 2010

Dieting to Reduce Diabetes Risk May Not Work in People With Low Muscle Mass

One of the factors that increases the risk of acquiring type 2 diabetes is excess body fat. So it makes sense that losing weight has always been one of the first lines of defense against the disease. Yet people who are slender -skinny, even- sometimes develop type 2. Why is that? Does the fact that a slender person can acquire type 2 negate the need for weight control?

comments 0 comments - Posted Jun 18, 2010

Italian Scientists Find a Viral Link to Type 1 Diabetes

Italian researchers have found a link between a common virus and type 1 diabetes that may open the door to answers about what triggers the disease in children.

comments 0 comments - Posted Jun 17, 2010

DKA and Infection Risk

Diabetic ketoacidosis poses enough of a threat on its own. But in a small number of cases, it leaves sufferers open to a potentially fatal infection called mucormycosis.

comments 0 comments - Posted Jun 12, 2010

Safe Chemicals Act of 2010 and You

We all know that certain chemicals in everyday products are harmful:  mercury and lead, just to name a couple. But how harmful, and what can we do about it?

comments 0 comments - Posted Jun 9, 2010

May 2010

Environmental Factors In Diabetes

Both genetic components and environmental factors play a role in most chronic diseases, including type 2 diabetes. In the same way that researchers use a Genome-Wide Association Study (GWAS) to evaluate the role of genetic factors in disease, scientists at Stanford University have used an Environmental-Wide Association Study (EWAS) to evaluate environmental factors on diabetes.

comments 0 comments - Posted May 29, 2010

Skimping on Sleep Linked to Diabetes and Higher Mortality Rates

As awareness of pre-diabetes grows, the list of conditions that can lead to it seems to be growing. Along with obesity and a sedentary lifestyle, researchers may start listing lack of sleep as another danger signal. Two recently published studies conclude that sleep deprivation can lead to insulin resistance-a precursor for diabetes-and even increase the risk of early death.

comments 0 comments - Posted May 26, 2010

Beware the Perils of Severe Hypoglycemia

Over 80 years ago, famed diabetologist Elliot Joslin said about the treatment of patients with type 1 diabetes: "Ketoacidosis may kill a patient, but frequent hypoglycemic reactions will ruin him."  Unfortunately, hypoglycemia continues to be the most difficult problem facing most patients, families, and caregivers who deal with the management of type 1 diabetes on a daily basis. Frequent hypoglycemia episodes not only can "ruin," or adversely impact the quality of life for patients, but also, when severe, can cause seizures, coma, and even death.

comments 13 comments - Posted May 13, 2010

Recruiting Patients with Newly Diagnosed Type 1 Diabetes

Dr. Richard Hays announced today that he is now recruiting children with newly diagnosed type 1 diabetes for Protégé Encore, a randomized, placebo-controlled Phase III clinical trial. This is the second of two Phase III studies testing the safety and efficacy of an investigational drug called teplizumab. The first study, known as Protégé, has completed enrollment of more than 530 subjects with type 1 diabetes. There is currently no approved therapy to slow the progression of type 1 diabetes.

comments 0 comments - Posted May 12, 2010

Stem Cell Treatment for Type 1 Diabetes

Osiris Therapeutics announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations. To be eligible for Orphan Drug designation, the treatment must target a disease that affects fewer than 200,000 new patients per year in the United States.

comments 0 comments - Posted May 7, 2010

April 2010

Oy! Cutting Calories May Actually Make You Put on Pounds

-SIGH- A pessimist might say that the following news is another sign that Mother Nature sometimes has one mean sense of humor: Reducing your caloric intake in order to lose weight may, ironically, lead to weight gain.

comments 3 comments - Posted Apr 29, 2010

February 2010

American Association of Clinical Endocrinologists Approves New Diagnosis for Diabetes

In addition to diagnosing type 2 diabetes based on fasting blood glucose levels or a glucose tolerance test, the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) have now approved the use of A1c as an additional diagnostic criterion for type 2 diabetes.

comments 2 comments - Posted Feb 5, 2010

UK Study Says Bisphenol A (BPA) Is Connected to Increased Risks for Diabetes and Coronary Heart Disease

A study by researchers at the universities of Exeter and Plymouth in the United Kingdom says that Bisphenol A-BPA-a chemical commonly used in plastic packaging and products, is associated with an increased risk of diabetes and coronary heart disease.

comments 1 comment - Posted Feb 2, 2010

January 2010

ProtoKinetix Anti-Aging Glycopeptides Show Promise Against Diabetes

One potential avenue for the treatment for type 1 diabetes is to transplant insulin-producing islet cells into the body. The Edmonton Protocol is a method of implanting pancreatic islets into the liver for the treatment of type 1 diabetes. The protocol is named for the islet transplantation group at the University of Alberta in Edmonton, Canada, where the protocol was first devised in the late 1990s.

comments 3 comments - Posted Jan 13, 2010

December 2009

Eliminating Endocrinologist Consultations

JACKSONVILLE, Fla., Dec. 7 -- A survey just conducted by the American Association of Clinical Endocrinologists (AACE) indicates that the Centers for Medicare & Medicaid Services (CMS) decision to eliminate consultation codes will force four out of five endocrinologists to reduce the number of Medicare patients seen in their practices.

comments 7 comments - Posted Dec 15, 2009

July 2009

Survey Says Most Endocrinologists and Physicians See a Need for More Byetta and Januvia-Type Drugs

High percentages of endocrinologists, primary care physicians, and managed care organizations surveyed by a research firm say they would like to see additional GLP-1 analogues like Amylin/Eli Lilly's Byetta® and DPP-IV inhibitors like Merck's Januvia® available to treat type 2 diabetes.

comments 6 comments - Posted Jul 25, 2009

January 2009

Supply and Demand

The treatment of diabetes has come a long way since Dr. Elliot Joslin wrote The Treatment of Diabetes Mellitus in 1916. But Dr. Joslin's idea that diet, exercise, and insulin (when it became available as therapy in 1922) are the keys to managing diabetes remains true today. This doesn't mean that diabetes is not a complex illness requiring ongoing education and individualized care. People with diabetes benefit greatly from the services of a team of health care professionals including a certified diabetes educator and an endocrinologist--a doctor who specializes in treating disorders of the endocrine system.

comments 7 comments - Posted Jan 21, 2009

November 2008

Thinking of Kids? Here’s Some Tips for Handling Pregnancy & Diabetes
Thinking of Kids? Here’s Some Tips for Handling Pregnancy & Diabetes

Becoming pregnant for the first time can be overwhelming for any woman, especially if that woman has diabetes. When my husband and I decided we were ready to have children, the first thing I did was make an appointment with my endocrinologist. Diagnosed when I was fourteen, I've had type 1 diabetes for twenty-four years. My doctor explained that I would need to be in tight control for three months before I could even think about babies, so I got right to work. Learning everything I could about diabetes and pregnancy, I was pleased to discover that with education, support, and practice, a woman with diabetes has every opportunity for a healthy pregnancy.

comments 7 comments - Posted Nov 17, 2008

Letter to the Editor: Reader Responds to Laura Plunkett’s Diabetes Health TV Interview
Letter to the Editor: Reader Responds to Laura Plunkett’s Diabetes Health TV Interview

Dear Laura,

I just finished viewing your clip online.  You seem like a very intelligent and involved mom who decided it was time to take charge.  I applaud you, and I agree with many points you make, but I disagree with your position on food.

comments 10 comments - Posted Nov 17, 2008

October 2008

The Future of Diabetes
The Future of Diabetes

I rush to the hospital, hoping to get there in time. When I arrive, I find my newly diagnosed diabetic with a blood sugar of 1027.  He is vomiting all over the place and might have a seizure soon.  He is in diabetic ketoacidosis. It's time for my dream job.

comments 5 comments - Posted Oct 13, 2008

August 2008

Family with Nine Kids, Three with Type 1, Finds There Are Some Silver Linings
Family with Nine Kids, Three with Type 1, Finds There Are Some Silver Linings

My husband and I have nine children. Elliott is our oldest and when he was diagnosed with type 1 at age 11 in 1996, we were blindsided. Neither my husband, nor I, nor anyone in our extended family had diabetes. Elliot had all of the classic symptoms: excessive thirst, frequent urination, uncontrollable hunger, occasional blurry vision, and (something I think a lot of parents don't recognize as a sign) bedwetting.  

comments 11 comments - Posted Aug 29, 2008

July 2008

Annual List of America's Best Hospitals Released
Annual List of America's Best Hospitals Released

“Let’s take care of the patient.” That must be the credo of hospitals that make U.S. News & World Report's “Best Hospitals” rankings, in which hospitals are judged not in routine procedures but in difficult cases across an entire specialty. In the nineteenth year of this annual review, hospitals are ranked in 16 specialties, from cancer and heart disease to respiratory disorders and urology. Out of the 5,453 hospitals put through a rigorous statistical mill, only 170 scored high enough to appear in any of the specialty rankings.

comments 2 comments - Posted Jul 17, 2008

NIH Funds Research in Four Countries to Improve Islet Transplantation
NIH Funds Research in Four Countries to Improve Islet Transplantation

The National Institutes of Health will fund studies at 11 research centers in the United States, Canada, Sweden and Norway to look into ways to improve outcomes and lessen the side effects from islet cell transplantations in people with type 1 diabetes.

comments 1 comment - Posted Jul 17, 2008

June 2008

Novo Nordisk Seeks U.S. and European Approval for Type 2 Drug Liraglutide
Novo Nordisk Seeks U.S. and European Approval for Type 2 Drug Liraglutide

Drug manufacturer Novo Nordisk has applied to the U.S. Federal Drug Administration and the European Medicines Agency for approval of liraglutide, a human GLP-1 analog* that is taken once daily for the treatment of type 2 diabetes.

comments 0 comments - Posted Jun 19, 2008

May 2008

AACE Calls for New Standards for Safer Insulin Pump Use

Newswise — “The American Association of Clinical Endocrinologists applauds the FDA’s efforts to protect the safety of children and adolescents who are using insulin pumps,” said Dr. Richard Hellman, the Association’s President.

comments 1 comment - Posted May 15, 2008

April 2007

A Leading Pediatric Endocrinologist Talks About Kids: Keeping BGs Steady
A Leading Pediatric Endocrinologist Talks About Kids: Keeping BGs Steady

What’s the most important goal for kids and families dealing with diabetes? Learn all you can, and then strive for the best possible blood glucose levels without excessive hypoglycemia. This is a tough goal to attain. Our tools, food, insulin, and monitoring, while the best they have ever been, are still imprecise. And although optimal glucose control is critical for immediate and long-term health, one must always be wary of severe and recurring hypoglycemia.

comments 0 comments - Posted Apr 13, 2007

March 2007

Interview with a Pediatric Endocrinologist: Dr. Morey Haymond
Interview with a Pediatric Endocrinologist: Dr. Morey Haymond

Q: Please describe your background.

Morey Haymond: A pediatric endocrinologist by training, I have been involved in metabolic studies of kids, infants, and adults for 35 years. I work with children who have disorders of carbohydrate metabolism, including diabetes and hypoglycemia. Understanding the regulation of those processes has been a focus of my research, and I have looked at amino acid and fat metabolism as well.

comments 1 comment - Posted Mar 29, 2007

April 2006

Use of Insulin Pumps in Patients With Type 2: An Endocrinologist’s View
Use of Insulin Pumps in Patients With Type 2: An Endocrinologist’s View

Recent developments in the treatment of diabetes mellitus have shown that “tight” control and intensive therapy are necessary to prevent complications, increased morbidity and mortality. We are all familiar with the findings of the DCCT and various UKPDS studies and sub-studies. The importance of these “landmark” studies does not need any further discussion at this time.

comments 2 comments - Posted Apr 1, 2006

April 2004

Case Management Improves Blood Glucose Control for Low-Income Minorities

“Diabetes case management can help reduce disparities in diabetes health status among low-income ethnic populations,” writes Lois Jovanovic, MD, endocrinologist and researcher at Sansum Medical Research Institute in Santa Barbara, California.

comments 0 comments - Posted Apr 1, 2004

May 2003

Help Wanted: Pediatric Endocrinologists

"Now is a wonderful time to consider a research career in childhood diabetes," says Georgeanna Klingensmith, MD, who heads the Division of Pediatrics at the Barbara Davis Center at the University of Colorado Health Sciences Center. "We need young people with energy and enthusiasm to take these new findings in molecular biology, genetics, and immunology and put them together to move the field ahead."

comments 0 comments - Posted May 1, 2003

April 2002

Choosing an Exercise Shoe

The type of shoe you choose for your walking or running activity may be the single best insurance you can buy to reduce your chance of injury. I find that most people look for two things in a shoe: cushion and style. The problem here is that cushion, while it may feel good initially, does not offer the stability that most people need. A lack of stability in a shoe can cause the majority of weight-bearing injuries to the ankles, knees, hips and lower back. Remember, it is nice to look good while you are exercising, but how can you continue to look good if you are injured?

comments 0 comments - Posted Apr 1, 2002

September 2001

Questions and Answers

I am in my 32nd week of pregnancy with my second child, and I wonder if I have developed gestational diabetes.

comments 0 comments - Posted Sep 1, 2001

June 2001

Advice...For Kids with Diabetes: 11 Things Your Pediatric Endocrinologist Should Tell You
Advice...For Kids with Diabetes: 11 Things Your Pediatric Endocrinologist Should Tell You

I am a pediatric endocrinologist. I have been in practice for 18 years and see 12 to 15 kids every day.

comments 0 comments - Posted Jun 1, 2001

September 2000

Interpreting Your C-peptide Values

Normal C-peptide levels for a fasting test are generally considered to be anything between 0.5 nanograms (ng) per millileter (ml) and 3 ng/ml, although people who do not have diabetes may occasionally stray out of this range. The following is a range of C-peptide values in people without diabetes, as compiled by Endocrine Sciences, Inc., a California-based laboratory that conducts the test. It should be noted that, in some cases, subjects fell below the normal range of C-peptide values, but were still not found to have diabetes. The range of values may also vary according to what lab your health care practitioner uses.

comments 11 comments - Posted Sep 1, 2000

May 2000

Endocrinologist Shares Creative Treatment Tips—Type 2 Diabetes in Five Stages

DIABETES HEALTH: The latest figures show that only five percent of people with diabetes see a diabetes specialist. Is there something seriously wrong here?

comments 0 comments - Posted May 1, 2000

December 1999

Why are Some Drugs So Expensive?—Endocrinologist Tells Consumer to Shop Around

One year ago, I was standing in line at a local pharmacy to purchase a prescription drug for my wife. The woman in front of me had given the pharmacist a prescription for a mild agent to help her son sleep. This drug is neither essential nor even clearly effective. As the pharmacist gave the woman the bottle of 30 pills, he asked her for $204.

comments 0 comments - Posted Dec 1, 1999

July 1995

Metformin: Who Should Take It?

Several prominent endocrinologists gathered in San Diego this past January to develop guidelines for prescribing metformin. Speaking at the American Diabetes Association Post-Graduate course were: Alan J. Garber, MD, PhD, of Houston's Baylor College of Medicine; Ralph A. DeFronzo, MD, Chief of the Diabetes Division of the University of Texas Health Center in San Antonio; and Jay S. Skyler, MD of Miami.

comments 0 comments - Posted Jul 1, 1995

September 1991

Vital Energy: A Scientific View of Diabetes

Diabetes is a disease of the substance sugar, but is really about energy. In the final analysis, diabetes is a disease of poor energy metabolism. It is manifest in problems with sugar, the crucial fuel, and insulin, the crucial energy hormone. To understand diabetes, we need to understand biological energy: where it comes from, what it is, and how it works.

comments 0 comments - Posted Sep 1, 1991

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.